LINDBORG STACY (EVP, Head Global Clin Research) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2025ACC: 0001104659-25-000889
Officer· EVP, Head Global Clin Research
Since Jun 2020
+20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
70.8%
1/1/2025
28.23K→48.23K
Total
Net shares
+20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2025 | A · Award | +20K | — | — | 70.8% | 28.23K | 48.23K |
| Total | +20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported